ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Allorecognition"

  • 2017 American Transplant Congress

    Reduction of Recipient Cell Cross-Dressing with Donor MHC Molecules Prolongs Allograft Survival in Mice.

    J. Marino, H. Tector, B. Gonzalez-Nolasco, A. Lellouch, A. Harney, C. Cetrulo, Jr, J. Markmann, G. Benichou.

    Center for Transplantation Sciences, Massachusetts General Hospital / Harvard Medical School, Boston, MA

    Cross-dressing of recipient cells with allogeneic MHC molecules carried by donor exosomes occurs regularly after transplantation. However, it is still unknown whether this phenomenon plays…
  • 2017 American Transplant Congress

    Donor Leukocytes Are Eliminated by the Host's Immune System Shortly After Skin Transplantation in Mice.

    J. Marino, B. Gonzalez-Nolasco, G. Benichou.

    Center for Transplantation Sciences, Massachusetts General Hospital / Harvard Medical School, Boston, MA

    We have recently reported the lack of donor passenger leukocytes in the recipient's lymphoid organs of mice recipient of a skin allograft. On the other…
  • 2017 American Transplant Congress

    2B4-Mediated Inhibition of Proliferation and Glycolytic Function Attenuates T Cell Alloreactivity.

    S. Laurie, D. Liu, M. Cortes, M. Wagener, M. Ford.

    Emory Transplant Center, Atlanta, GA

    Current thinking holds that costimulation-blockade resistant graft rejection may be mediated by CD28null T cells. To further investigate this possibility, we performed a retrospective immunophenotypic…
  • 2017 American Transplant Congress

    Does HLA Class of Complement Activating Donor Specific Antibodies Matter: Single Centre Retrospective Analysis of Renal Allograft Outcomes.

    A. Babu,1,2,3 D. Briggs,3 D. Mitchell,1 N. Krishnan,2 R. Higgins,1 S. Daga.1,2,4

    1Warwick Medical School, University of Warwick, Coventry, United Kingdom; 2Nephrology and Transplantation, University Hospitals Coventrya and Warwickshire, Coventry, United Kingdom; 3Histocompatibility and Immunogenetics, NHS Blood and Transfusion, Birmingham, United Kingdom; 4Nephrology and Transplantation, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

    Introduction. Complement activating donor specific antibodies may be associated with worse outcomes in a cohort of patients who have undergone HLA-AIT. We looked for differences…
  • 2017 American Transplant Congress

    Rapamycin Directly Alters Human Endothelial Cell Alloimmunogenicity.

    V. Bendersky,1 H. Xu,2 A. Kirk.2

    1School of Medicine, Duke University, Durham, NC; 2Department of Surgery, Duke University, Durham, NC

    The mTOR inhibitor rapamycin (Rapa) is known to suppress T cell function. However, many of its in vivo effects, particularly its synergistic effects with costimulation…
  • 2017 American Transplant Congress

    Exosomes Containing IL35 Are Secreted by Donor-Specific Regulatory T Cells and Cause Linked-Suppression.

    Y. Tomita,1 W. Bracamonte-Baran,1 E. Jankowska-Gan,1 Q. Zhang,2 D. Vignali,2 W. Burlingham.1

    1Surgery, Transplant Division, University of Wisconsin-Madison, Madison, WI; 2Immunology, University of Pittsburgh, Pittsburgh

    Introduction: We previously reported that donor specific splenocytes transfusion (DST) plus anti-CD40L costimulatory blockade treatment causes allo-specific regulation approximately 5 weeks after the tolerization. The…
  • 2017 American Transplant Congress

    Role of Donor-Derived Tissue Resident Memory T cells in Modulating Alloimmunity.

    R. Crepeau, D. Liu, M. Ford.

    Emory Transplant Center, Emory University, Atlanta, GA

    Recipient-derived, graft-specific memory T cells play a critical role in mediating allograft rejection, particularly in the setting of immunosuppression with costimulation blockade. Recently, it is…
  • 2017 American Transplant Congress

    Refinement of an Old Faithful: A Standardized Flow Cytometry Approach to Measure Donor-Recipient Alloreactivity (a Pilot Study).

    A. Halpin,1 M. Sosniuk,1 S. Urschel,1 P. Campbell,2 I. Larsen,1 L. West.1

    1Pediatrics, Alberta Transplant Institute, Canadian National Transplant Reseach Program, University of Alberta, Edmonton, Canada; 2Lab Medicine and Pathology, University of Alberta, Edmonton, Canada

    Purpose: Donor-specific antibody (DSA) and antibody (Ab)-mediated rejection are challenges in long-term outcomes and limit re-transplantation. Sensitizing events such as homografts in surgical procedures, assist…
  • 2016 American Transplant Congress

    Rapid Emergence of CD28null Cells Following Ex Vivo Restimulation Is Associated with Belatacept Resistant Rejection.

    M. Cortes, S. Laurie, B. Sayed, M. Ford.

    Emory Transplant Center, Atlanta, GA.

    Numerous studies have implicated donor-reactive memory T cells in mediating costimulation blockade resistant rejection (CoBRR) following treatment with belatacept. In humans, these memory T cells…
  • 2016 American Transplant Congress

    The Presence of CMV-Specific T-Cells in CMV-Seronegative Kidney Transplant Recipients Predicts Outcome After Kidney Transplantation.

    T. Schachtner,1,2 M. Stein,2 P. Reinke.1,2

    1Nephrology and Internal Intensive Care, Charite Campus Virchow Clinic, Berlin, Germany; 2Berlin-Brandenburg Center for Regenerative Therapies, Charite Campus Virchow Clinic, Berlin, Germany.

    CMV-seronegative kidney transplant recipients (KTRs) from CMV-seropositive donors are at highly increased risk of primary CMV-infection with associated inferior outcomes after kidney transplantation. Presence of…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 16
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences